Stay updated on Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision update: v3.3.1 → v3.3.2; no substantive changes to the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoChange DetectedPublications section wording updated to indicate that these publications are provided voluntarily by the person entering information about the study and are about the results. The revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the banner that informed users about government funding and potential delays in updates. The notice previously cautioned that the information on the site may not be up to date during funding lapses.SummaryDifference0.3%

- Check33 days agoChange DetectedNo significant changes detected on the Study Details page; the overview, objectives, eligibility criteria, and listed locations remain unchanged.SummaryDifference0.4%

- Check62 days agoChange Detected- Added a government funding notice about potential delays and current operating status, plus a link to cc.nih.gov and opm.gov for updates. - Bumped version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check69 days agoChange DetectedAdditions add broader economics topics and a new v3.1.0 release; deletions remove several biology topics and an older v3.0.2 release. The page is shifting focus toward economics-related content with a platform update.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.